Royalty Pharma Plc
Stock Chart, Company Information, and Scan Results
$36.59(as of Sep 4, 1:34 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Royalty Pharma Plc Company Information, Fundamentals, and Technical Indicators
Stock Price$36.59
Ticker SymbolRPRX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
EmployeesUnknown
CountyUSA
Market Cap$21,093.4M
EBIDTA1,497.8M
P/E Ratio20.20
Forward P/E Ratio11.92
Earnings per Share2.29
Profit Margin5.21%
RSI55.31
Shares Outstanding432.3M
ATR0.72
52-Week High37.77
Volume5,815,472
52-Week Low23.59
Book Value9,502.9M
P/B Ratio2.17
Upper Keltner37.89
P/S Ratio8.94
Lower Keltner34.65
Debt-to-Equity Ratio37.89
Next Earnings Date11/05/2025
Cash Surplus-574.6M
Next Ex-Dividend DateUnknown
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Royalty Pharma Plc In Our Stock Scanner
As of Sep 04, 2025
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.